Ticker

Hydreight Technologies is downgraded from Strong Buy to Buy after Q2 2026 revealed slowing sequential growth and margin pressure. NURS Q2 revenue grew 12% QoQ to $28M, missing expectations and raising concerns about achieving FY2026's $150M guidance. Gross margin fell to 19.4% due to increased pharmacy sales and pricing concessions, while cash burn remained elevated amid rapid expansion.

Big Yellow Group is upgraded to 'Buy' with a £9.20/share price target, reflecting an attractive valuation after sector normalization. BYG's fundamentals remain solid despite sector headwinds; current sub-£9/share levels imply limited downside and a compelling 5-6% yield. Occupancy has declined from ~79% to

Yellow Pages TSE: Y reported lower second-quarter revenue and adjusted EBITDA as continued declines in its digital and print products weighed on results, although the company said cost discipline and operating efficiencies supported profitability and cash generation.

Yellow Cake offers low-risk, passive uranium exposure, currently trading at a 17–26% discount to NAV, making it attractively valued. Uranium's supply/demand dynamics remain favorable, with ongoing deficits, slow mine restarts, and ambitious global nuclear expansion targets supporting long-term price strength. YLLXF's recent 60-day buyback program enhances per-share uranium exposure, addressing prior concerns over…

SUMMARY The Fed is on hold as inflation concerns continue. The US Trend remains positive and has regained short-term momentum.